2004
DOI: 10.1016/j.burns.2003.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Serum levels of vancomycin should be monitored in burn patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0
1

Year Published

2007
2007
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 11 publications
0
6
0
1
Order By: Relevance
“…Patients with burns were not eligible because of the significant differences in vancomycin pharmacokinetics in this population. [21][22][23][24][25][26][27][28] …”
Section: Study Sitementioning
confidence: 99%
“…Patients with burns were not eligible because of the significant differences in vancomycin pharmacokinetics in this population. [21][22][23][24][25][26][27][28] …”
Section: Study Sitementioning
confidence: 99%
“…Studies focusing specifically on burn patients are scarce, and no recommendation has been established regarding empirical initial doses of anti-infective agents in burn victims [10,[20][21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…The structures [8][9][10][11]13] and pK a values [8][9][10]12,13] of these compounds are outlined in Table 1. The simultaneous determination of AMI with some other antidepressants such as NOR [14][15][16][17] or IMI [18] or AMI, NOR and IMI [19][20][21][22][23][24][25] were performed by CE in recent years. The determination of CHL in combination with AMI was carried out by microchip CE [26].…”
Section: Introductionmentioning
confidence: 99%